Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Ubrogepant Acute migraine
.
Show all posts
Showing posts with label
Ubrogepant Acute migraine
.
Show all posts
Friday, May 3, 2019
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
›
Allergan plc (NYSE: AGN) announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Applicati...
›
Home
View web version
